Suppr超能文献

表达显性和隐性TCR的甲型流感特异性细胞毒性T淋巴细胞克隆之间的功能差异。

Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.

作者信息

Lawson T M, Man S, Wang E C, Williams S, Amos N, Gillespie G M, Moss P A, Borysiewicz L K

机构信息

Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK.

出版信息

Int Immunol. 2001 Nov;13(11):1383-90. doi: 10.1093/intimm/13.11.1383.

Abstract

We have shown that the dominance of CD8+ T cells expressing TCR Vbeta17 in the adult HLA-A0201-restricted influenza A/M1(58-66)-specific response is acquired following first antigen exposure. Despite the acquired dominance of Vbeta17+ cells, subdominant M1(58-66)-specific clones expressing non-Vbeta17+ TCR persist in all individuals. To determine whether the affinity of the expressed TCR for the HLA-A0201/M1(58-66) complex could influence functional properties, M1(58-66)-specific clones expressing subdominant (non-Vbeta17+) TCR were compared to cytotoxic T lymphocyte (CTL) clones expressing dominant (Vbeta17+) TCR. The Vbeta17+ CTL required up to 10,000-fold lower amounts of M1 peptide to mediate lysis compared to CTL clones expressing other Vbeta gene segments. All Vbeta17+ CTL clones tested bound HLA-A0201/M1(58-66) tetramer, but two of three CTL clones expressing other TCR did not bind tetramer. The inability of non-Vbeta17+ CTL to bind tetramer did not correlate with phenotype, CD8 dependence or with cytokine production profiles. This suggests a limitation for the use of tetramers in examining subdominant T cell responses. Together these findings suggest that Vbeta17+ CTL which dominate the HLA-A0201-restricted CTL response against influenza A are not functionally distinct from subdominant non-Vbeta17+ CTL. The dominance of Vbeta17+ CTL is likely to result from a competitive advantage due to superior CTL avidity for the HLA-A*0201/M1(58-66) complex.

摘要

我们已经表明,在成人HLA - A0201限制性甲型流感病毒A/M1(58 - 66)特异性反应中,表达TCR Vβ17的CD8 + T细胞的优势是在首次接触抗原后获得的。尽管Vβ17 +细胞获得了优势,但表达非Vβ17 + TCR的亚优势M1(58 - 66)特异性克隆仍存在于所有个体中。为了确定所表达的TCR对HLA - A0201/M1(58 - 66)复合物的亲和力是否会影响功能特性,将表达亚优势(非Vβ17 +)TCR的M1(58 - 66)特异性克隆与表达优势(Vβ17 +)TCR的细胞毒性T淋巴细胞(CTL)克隆进行了比较。与表达其他Vβ基因片段的CTL克隆相比,Vβ17 + CTL介导裂解所需的M1肽量低至10000倍。所有测试的Vβ17 + CTL克隆都能结合HLA - A0201/M1(58 - 66)四聚体,但表达其他TCR的三个CTL克隆中有两个不能结合四聚体。非Vβ17 + CTL不能结合四聚体与表型、CD8依赖性或细胞因子产生谱无关。这表明在检查亚优势T细胞反应时使用四聚体存在局限性。这些发现共同表明,在HLA - A0201限制性CTL对甲型流感病毒的反应中占主导地位的Vβ17 + CTL与亚优势非Vβ17 + CTL在功能上并无差异。Vβ17 + CTL的优势可能是由于其对HLA - A*0201/M1(58 - 66)复合物具有更高的CTL亲和力而产生的竞争优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验